FDA shares eased manufacturing rules for cell and gene therapiesnews2026-01-12T18:04:55+00:00January 12th, 2026|Endpoints News|
Krystal Biotech says it can deliver native protein to cystic fibrosis patientsnews2026-01-09T15:26:44+00:00January 9th, 2026|Endpoints News|
Medipost gets $140M to take Korean stem cell therapy into USnews2026-01-09T11:30:58+00:00January 9th, 2026|Endpoints News|
Gene editing pioneers launch first startup focused on custom CRISPR therapiesnews2026-01-09T11:00:27+00:00January 9th, 2026|Endpoints News|
Secretive Rampart Bioscience closes after pursuing non-viral gene therapynews2026-01-08T17:59:21+00:00January 8th, 2026|Endpoints News|
Tessera Therapeutics to lay off 90 employees, according to documentnews2026-01-08T12:29:39+00:00January 8th, 2026|Endpoints News|
Beacon Therapeutics adds $75M in push to succeed where J&J failed in vision treatmentnews2026-01-08T12:00:44+00:00January 8th, 2026|Endpoints News|
As gene editing tools multiply, the hunt for the final technology continuesnews2025-12-29T17:02:50+00:00December 29th, 2025|Endpoints News|
Catalent handed two Form 483s for Maryland gene therapy sitesnews2025-12-19T12:25:40+00:00December 19th, 2025|Endpoints News|
Addition Therapeutics raises $106.5M for all RNA ‘jumping gene’ therapiesnews2025-12-17T13:22:29+00:00December 17th, 2025|Endpoints News|
